XML 34 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (USD $)
In Millions, unless otherwise specified
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Cash flows from operating activities    
Net (loss) income $ (36.7) $ 12.6
Adjustments to reconcile net (loss) income to net cash provided by operating activities    
Depreciation and amortization 50.6 51.1
Provision for loss on receivables 2.6 3.8
Loss from CyrusOne equity method investment 1.9 0
Noncash portion of interest expense 2.0 2.0
Deferred income tax provision 6.1 12.4
Pension and other postretirement payments in excess of expense (3.1) (8.2)
Stock-based compensation 2.3 1.3
Loss on sale or disposal of assets, net 2.5 0
Excess tax benefit for share based payments (0.5) 0
Other, net (0.1) 0.9
Changes in operating assets and liabilities, net of CyrusOne deconsolidation:    
Decrease (increase) in receivables 6.5 (0.4)
Increase in inventory, materials, supplies, prepaid expenses and other current assets (5.3) (5.5)
Increase (decrease) in accounts payable 23.4 (36.5)
Decrease in accrued and other current liabilities (0.9) (8.8)
Decrease (increase) in other noncurrent assets 0.4 (0.2)
Decrease in other noncurrent liabilities (9.4) (0.9)
Net cash provided by operating activities 42.3 23.6
Cash flows from investing activities    
Capital expenditures (50.9) (84.6)
Proceeds from sale of assets 0.8 0
Release of restricted cash 0.4 0
Cash divested from deconsolidation of CyrusOne (12.2) 0
Net cash used in investing activities (61.9) (84.6)
Cash flows from financing activities    
Borrowing on receivables facilities, net 2.0 0
Repayment of debt (3.1) (4.0)
Dividends paid on preferred stock (2.6) (2.6)
Common stock repurchase 0 (0.3)
Proceeds from exercise of options and warrants 6.6 0
Excess tax benefit for share based payments 0.5 0
Other, net (2.3) 1.1
Net cash provided by (used in) financing activities 1.1 (5.8)
Net decrease in cash and cash equivalents (18.5) (66.8)
Cash and cash equivalents at beginning of period 23.6 73.7
Cash and cash equivalents at end of period 5.1 6.9
Noncash investing and financing transactions:    
Investment in CyrusOne resulting from deconsolidation 509.7 0
Accrual of CyrusOne dividends 7.1 0
Acquisition of property by assuming debt and other noncurrent liabilities 1.0 1.4
Acquisition of property on account $ 25.4 $ 13.3